These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 318788

  • 1. Stimulatory effect of the dopa-decarboxylase inhibitor Ro 4-4602 on prolactin release; inhibition by l-dopa, metergoline, methysergide and 2-Br-alpha-ergocryptine.
    Pontiroli AE, Castegnaro E, Vettaro MP, Viberti GC, Pozza G.
    Acta Endocrinol (Copenh); 1977 Jan; 84(1):36-44. PubMed ID: 318788
    [No Abstract] [Full Text] [Related]

  • 2. Stimulating action of sulpiride and pimozide on prolactin release. Effect on bromocriptine, L-dopa and metergoline administration.
    Delitala G.
    Acta Endocrinol (Copenh); 1977 Oct; 86(2):251-6. PubMed ID: 578618
    [Abstract] [Full Text] [Related]

  • 3. Growth hormone and prolactin release in acromegalic patients following metergoline administration.
    Delitala G, Masala A, Alagna S, Devilla L, Lotti G.
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1382-6. PubMed ID: 1002821
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of prolactin release by serotonin antagonists in hyperprolactinemic subjects.
    Ferrari C, Caldara R, Rampini P, Telloli P, Romussi M, Bertazzoni A, Polloni G, Mattei A, Crosignani PG.
    Metabolism; 1978 Oct; 27(10):1499-504. PubMed ID: 692379
    [Abstract] [Full Text] [Related]

  • 5. Metaclopramide and prolactin secretion in man: effects of pretreatment with L-dopa and 2-bromo-alpha-ergocryptine (CB-154).
    Delitala G, Masala A, Alagna S, Devilla L.
    IRCS J Med Sci; 1975 Jun; 3(6):274. PubMed ID: 1165172
    [No Abstract] [Full Text] [Related]

  • 6. The effect of 2-bromo-alpha-ergocryptine and 2-chloro-alpha-methylergoline-8beta-acetonitrile (lergotrile mesylate) on the prolactin secretion of the ewe.
    Hooley RD, Fell LR, Findlay JK.
    Acta Endocrinol (Copenh); 1977 Dec; 86(4):722-7. PubMed ID: 411304
    [Abstract] [Full Text] [Related]

  • 7. [Growth hormone secretion induced by L-Dopa and a dopa decarboxylase inhibitor blocked by free fatty acids].
    Casanueva F, Villanueva L, Peñalva A, Barrionuevo JA, Vila T, Cabezas-Cerrato J.
    Rev Clin Esp; 1979 May 15; 153(3):221-4. PubMed ID: 482695
    [No Abstract] [Full Text] [Related]

  • 8. The effect of L-dopa with and without decarboxylase inhibitor on growth hormone secretion in children with short stature.
    Fevang FO, Stoa RF, Thorsen T, Aarskog D.
    Acta Paediatr Scand; 1977 Jan 15; 66(1):81-4. PubMed ID: 831384
    [Abstract] [Full Text] [Related]

  • 9. Mechanisms involved in the prolactin-releasing effect of benserazide.
    Parati EA, Penalva A, Bondiolotti GP, Parenti M, Locatelli V, Picotti GB, Cocchi D, Müller EE.
    Eur J Pharmacol; 1984 Jun 01; 101(3-4):215-21. PubMed ID: 6468496
    [Abstract] [Full Text] [Related]

  • 10. Mechanisms underlying the prolactin-lowering effect of meterogoline in the rat.
    Cocchi D, Locatelli V, Carminati R, Müller EE.
    Life Sci; 1978 Sep 04; 23(9):927-36. PubMed ID: 703523
    [No Abstract] [Full Text] [Related]

  • 11. Interaction of dopaminergic and antiserotoninergic drugs in the control of prolactin and LH release in normal women.
    Pontiroli AE, Alberetto M, Pellicciotta G, De Castro e Silva E, De Pasqua A, Girardi AM, Pozza G.
    Acta Endocrinol (Copenh); 1980 Mar 04; 93(3):271-6. PubMed ID: 7376792
    [Abstract] [Full Text] [Related]

  • 12. Metergoline as a lactation inhibitor.
    Caballero A, Palomo A, Molina CE, Albarrán FJ, Caballero A, Mena P.
    J Reprod Med; 1982 Apr 04; 27(4):202-6. PubMed ID: 7097670
    [Abstract] [Full Text] [Related]

  • 13. Effects of oestrogen and bromocryptine on in vivo secretion and mitosis in prolactin cells.
    Lloyd HM, Meares JD, Jacobi J.
    Nature; 1975 Jun 05; 255(5508):497-8. PubMed ID: 1138203
    [No Abstract] [Full Text] [Related]

  • 14. [Our experience in the inhibition of lactation (Controlled clinical study with bromocriptine, methergoline and pyridoxine)].
    Vecchione A, Baccolo M.
    Riv Ital Ginecol; 1980 Jun 05; 59(2-3):311-9. PubMed ID: 7020052
    [No Abstract] [Full Text] [Related]

  • 15. Effect of two antiserotoninergic drugs, methysergide and metergoline, on gastric acid secretion and gastrin release in healthy man.
    Caldara R, Ferrari C, Barbieri C, Romussi M, Rampini P, Telloli P.
    Eur J Clin Pharmacol; 1980 Jan 05; 17(1):13-8. PubMed ID: 7371695
    [Abstract] [Full Text] [Related]

  • 16. TSH and prolactin stimulation by the decarboxylase inhibitor benserazide in primary hypothyroidism.
    Delitala G, Devilla L, Lotti G.
    Clin Endocrinol (Oxf); 1980 Mar 05; 12(3):313-6. PubMed ID: 7389157
    [Abstract] [Full Text] [Related]

  • 17. Effect of prolactin inhibitory agents on the ectopic anterior pituitary and the mammary gland in rats.
    Gräf KJ, Horowski R, Etreby MF.
    Acta Endocrinol (Copenh); 1977 Jun 05; 85(2):267-78. PubMed ID: 325978
    [Abstract] [Full Text] [Related]

  • 18. Interaction of sulfpride and ergot derivatives on rat brain DOPAC concentration and prolactin secretion in vivo.
    Hofmann M, Battaini F, Tonon G, Trabucchi M, Spano P.
    Eur J Pharmacol; 1979 Jun 05; 56(1-2):15-20. PubMed ID: 467503
    [Abstract] [Full Text] [Related]

  • 19. [Effects of benserazide administration on prolactin secretion].
    Masturzo P, Murialdo G, Gallamini A, Nizzo MC, Magnani G.
    Boll Soc Ital Biol Sper; 1978 Feb 15; 54(3):274-8. PubMed ID: 687436
    [No Abstract] [Full Text] [Related]

  • 20. Metergoline inhibition of thyrotrophin and prolactin secretions in primary hypothyroidism.
    Delitala G, Rovasio PP, Masala A, Alagna S, Devilla L.
    Clin Endocrinol (Oxf); 1978 Jan 15; 8(1):69-73. PubMed ID: 627092
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.